The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.

Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take ...

It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...

Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take ...

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

“We want to focus on food. People forget that the ‘F’ in FDA stands for food,” Makary said. Makary noted that the processed ...

The lawsuit alleges that a decision in May to remove COVID-19 vaccines from the federal list of recommended vaccines for ...

FDA Commissioner Marty Makary suggests his agency may expedite drug reviews for manufacturers reducing U.S. prices to global ...

The idea could help the administration achieve one of President Donald Trump’s main health-care goals: ensuring foreign ...

FDA Commissioner Dr. Marty Makary joins ‘Fox & Friends’ co-host Steve Doocy for a morning walk to discuss the agency’s focus on food safety and the Make America Healthy Again movement.

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...